Benzinga's Top Upgrades

Analysts at Raymond James upgraded United States Cellular USM from “underperform” to “market perform.” United States Cellular's shares closed at $37.17 yesterday. United States Cellular's trailing-twelve-month ROE is 5.55%. Analysts at JP Morgan upgraded Rockwell Automation ROK from “neutral” to “overweight.” Rockwell Automation's shares closed at $74.87 yesterday. Rockwell Automation's PEG ratio is 1.21. Analysts at Deutsche Bank upgraded TrueBlue TBI from “hold” to “buy.” TrueBlue's stock closed at $13.16 yesterday. TrueBlue's trailing-twelve-month operating margin is 3.82%. Analysts at Piper Jaffray upgraded Watson Pharmaceuticals WPI from “neutral” to “overweight.” Watson Pharmaceuticals' shares closed at $87.71 yesterday. Watson Pharmaceuticals' trailing-twelve-month revenue is $5.51 billion.